Webinars & e-learning courses All webinars

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats
Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Tumors of the skin and subcutaneous tissues are the most common malignancies in dogs and cats accounting for over 30-40% of tumors in dogs and 29% in cats. Surgery is typically the first line treatment for most cutaneous and subcutaneous malignancies, and the phrase ‘a chance to cut is a chance to cure’ is certainly accurate with respect to many tumors.
Mast cell tumors and soft tissue sarcomas are the two most common skin malignancies in dogs whereas they are the third and fourth most common skin malignancies in cats (behind squamous cell carcinoma and basal cell tumors). This presentation will focus on mast cell tumors and soft tissue sarcomas in both species (squamous cell carcinomas and basal cell tumors will not be covered). The presentation will cover biologic behaviour of these tumors, considerations for staging and work-up, and treatment options with a focus on surgery, but discussion on adjuvant and alternative treatment methods will also be covered.

Recording from 30 June 2021

Speaker:

Dr-Stephanie-Colthurst-new.jpg

Stephanie Colthurst

Dr Stephanie Colthurst - Surgery BVSc. (James Cook)

Stephanie is a small animal surgeon at Veterinary Specialist Services in Brisbane (Australia). She has worked in referral practice for 9 years. Following graduation from James Cook University in 2014, she completed a 12-month rotating internship at Veterinary Specialist Services followed by a second internship at Southpaws in Melbourne (Australia) in 2016 before enrolling into a surgical residency at Southpaws through the European College of Veterinary Surgeons (ECVS).

Stephanie successfully passed her memberships of the Australian and New Zealand College of Veterinary Scientists in Small Animal Surgery in 2018 and has just successfully passed her ECVS board examinations in February 2023 on her first attempt.

Stephanie returned to Veterinary Specialist Services in 2021. Whilst she enjoys all aspects of surgery, her particular interests are in soft tissue and oncologic surgery. She is passionate about keeping up to date with advances in veterinary research, so that she can strive to provide the best possible care for each patient and their owner.

Booking information

Duration: 0:51 h
Speaker: Stephanie Colthurst
from 1
54.90 US$
(incl. tax)

You might also be interested in

canine-and-feline-lymphoma-diagnosis-and-treatment-1.jpeg
Peter Bennett
0:59 h

Canine and feline lymphoma - diagnosis and treatment

Canine and feline lymphoma is a relatively common disease but there are some areas where potential complications arise. This webinar will concentrate on the diagnostic tests that can be utilised for this disease and the common treatments, with an emphasis on how the diagnostic tests can influence the treatment and prognosis. In dogs, diagnosis is usually relatively straightforward, but it can be more of a challenge in cats due to the differences in clinical presentation. The standard initial treatment options are well described, but how they need to be modified dependent on concurrent illnesses, diagnostic test findings and owner constraints can be more complicated. My approach to these issues will be described including how they might impact the patient outcome, as well as alternatives. The monitoring of the patients and an overview of the management of complications of the disease and treatment is to be covered. The webinar will conclude with rescue options. Lymphoma can be a rewarding disease to treat, but can be very challenging at times.
tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice

Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
300x200.jpg
Momoko Ito
0:53 h

Nursing the end-stage cancer patient 

As veterinary patients age, they are more susceptible to diseases and cancer. This webinar will cover the basic cancer biology, treatment options and palliative care...